Investment Summary |
|
---|---|
Date | 2017-11-15 |
Target | Outpost Medicine |
Sector | Life Science |
Investor(s) |
Vivo Capital
Frazier Healthcare Partners Adams Street Partners |
Deal Type | Venture |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Growth Capital Firm |
---|---|
Founded | 1996 |
PE ASSETS | 6.4B USD |
Size | Mega |
Type | Sector Focused |
Vivo Capital is a healthcare investment firm focused on opportunities throughout the US and China. Specific areas of interest include biopharmaceuticals, specialty pharmaceuticals, and medical devices. The Firm looks to identify and work with companies at the development and commercial stage products in the US and at the revenue stage in China. Vivo Capital was established in 1997 and is headquartered in Palo Alto, California.
DEAL STATS | # |
---|---|
Overall | 13 of 18 |
Sector (Life Science) | 9 of 13 |
Type (Venture) | 10 of 13 |
State (Indiana) | 1 of 1 |
Country (United States) | 12 of 15 |
Year (2017) | 3 of 4 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2017-11-08 |
Apellis Pharmaceuticals
Waltham, Massachusetts, United States Apellis Pharmaceuticals is a clinical-stage biopharmaceutical company, focused on the development of a platform of novel therapeutic compounds for the treatment of a broad range of autoimmune diseases based upon complement immunotherapy. Uncontrolled complement activation can lead to a wide range of life-threatening or debilitating disorders. Apellis is the first company to advance chronic therapy with a C3 inhibitor into clinical trials. Apellis Pharmaceuticals was founded in 2009 and is headquartered in Waltham, Massachusetts. |
Sell | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2017-11-27 |
Medeor Therapeutics
San Mateo, California, United States Medeor Therapeutics is a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of personalized cellular immunotherapies to improve outcomes in organ transplant recipients. Medeor Therapeutics is based in San Mateo, California. |
Buy | - |
Category | Growth Capital Firm |
---|---|
Founded | 1991 |
PE ASSETS | 3.4B USD |
Size | Large |
Type | Sector Focused |
Frazier Healthcare Partners is a private equity and venture capital firm specializing in Growth buyout investment specifically targets businesses that deal Healthcare, Life Sciences, Pharmaceutical services, medical products, and related sectors. Frazier Healthcare Partners was formed in 1991 and is based in Seattle, Washington with an additional office in Palo Alto, California; Boston, Massachusetts; and Menlo Park, California.
DEAL STATS | # |
---|---|
Overall | 28 of 48 |
Sector (Life Science) | 10 of 17 |
Type (Venture) | 10 of 12 |
State (Indiana) | 1 of 1 |
Country (United States) | 27 of 47 |
Year (2017) | 6 of 7 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2017-11-03 |
AppianRx
Houston, Texas, United States AppianRx is a specialty pharmacy focused on providing comprehensive and customized manufacturer patient support services and specialty pharmacy solutions. AppianRx leverages its unique and proprietary technology platform to deliver personalized services faster, smarter and more efficiently for patients, providers and manufacturer partners. AppianRx was founded in 1992 and is based in Houston, Texas. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2017-12-29 |
Vein Clinics of America
Downers Grove, Illinois, United States Vein Clinics of America is a provider of treatments for chronic venous insufficiency (e.g., varicose veins) primarily through vein ablation and sclerotherapy procedures. Vein Clinics of America operates 58 outpatient vein clinics in 14 states. Vein Clinics of America was founded in 1981 and is based in Downers Grove, Illinois. |
Buy | - |
Category | Asset Manager |
---|---|
Founded | 1972 |
PE ASSETS | 60.0B USD |
Size | Mega |
Type | Sector Agnostic |
Adams Street Partners is a diversified, global investment firm that targets direct, fund of funds, and secondary investments. Adams' direct investing group covers co-investments in buyout transactions, as well as growth equity and venture capital commitments. The direct buyout and growth equity team looks to commit $5 to $30 million per transaction. For venture related investments, commitments of $5 to $20 million are provided to companies in the technology, life sciences and technology enabled services sectors. Typically, target companies have received prior financing from early stage venture firms and are seeking additional capital to fund product development and commercialization. Adams Street Partners was formed in 1972 and is based in Chicago, Illinois.
DEAL STATS | # |
---|---|
Overall | 110 of 148 |
Sector (Life Science) | 15 of 23 |
Type (Venture) | 79 of 100 |
State (Indiana) | 2 of 2 |
Country (United States) | 99 of 136 |
Year (2017) | 7 of 9 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2017-11-01 |
Accretive Solutions
Chicago, Illinois, United States Accretive Solutions, Inc. is a provider of business consulting and executive search services in the areas of accounting and finance, enterprise governance, and business and technology. Accretive Solutions was founded in1999 and is based in Chicago, Illinois. |
Sell | $19M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2017-11-29 |
US Med-Equip
Houston, Texas, United States US Med-Equip is a distributor and rental and related services provider of mission-critical moveable medical equipment used in hospitals. The Company provides equipment rentals across four product categories respiratory, infusion, monitoring, and central supply / NICU. US Med-Equip was founded in 2003 and is based in Houston Texas. |
Buy | - |